SQZ News and Press, SQZ Biotechnologies Company From 06/09/21

Engineered TACs Prevented Hyperglycemia in Type 1 Diabetes Models by Deletion of Target T Cells and Increase of Regulatory T Cells that Exerted Potent Bystander Suppression Data Presented at Federation of Clinical Immunology Societies SQZ Biotechnologies Company ...

Doses of Autologous Cell Therapy Manufactured in Under 24 Hours and Available to Patients in Approximately One Week Clinical Trial Findings Presented at the American Society of Clinical Oncology Annual Meeting SQZ Biotechnologies Company (NYSE: SQZ), focused on unloc...

ASCO is a very important cancer clinical research meeting. We identified 70 smid-cap cancer companies presenting updated clinical data at ASCO21. 13 companies' value increased by over 10% with ASCO21 info release thus far. PDSB is an early ASCO21 mover, with its HPV vaccine ca...

SQZ Biotechnologies Company (NYSE:SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that management will be participating in the Jefferies Virtual Healthcare Conference taking place June 1-4, 2021. Armon Sharei, PhD, chief executive...

SQZ Biotechnologies Company (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, will present safety and tolerability, manufacturing, and antitumor activity data from its ongoing Phase 1 clinical trial of SQZ-PBMC-HPV-101 in patients with advan...

SQZ Biotechnologies (SQZ): Q1 GAAP EPS of -$0.59 beats by $0.10.Revenue of $5.45M (-15.0% Y/Y) misses by $0.09M.Cash and cash equivalents as of March 31, 2021 was $204.9 million compared to $170.4 million as of December 31, 2020.Press Release For further details see: SQZ Biotechnologies...

SQZ Biotechnologies Company (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today reported financial results for the period ended March 31, 2021 and reviewed recent business highlights. “We continue to execute across our broad a...

SQZ Biotechnologies (NYSE:SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that management will be participating in the BofA (Bank of America) Securities 2021 Virtual Health Care Conference taking place May 11-13, 2021. Armon Share...

SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, announced today that it will present new data on the company’s scaled cGMP cell therapy manufacturing program at the 2021 American Society for Gene and Cell Therapy...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...